CLAIM CARD
Mechanistically, colchicine's anti-inflammatory actions are well-characterized: it inhibits neutrophil chemotaxis, NLRP3 inflammasome activation, and microtubule-dependent cellular processes (Deftereos 2020; Imanishi 2026). These pharmacological properties provide biological plausibility for effects on inflammaging pathways. However, direct evidence that colchicine attenuates inflammaging biomarkers in human aging populations remains sparse, with most clinical data originating from cardiovascular event trials rather than aging-specific endpoints.
Evidence grade: exploratory
Contradiction status: none
Publication: 873ff54a-3a1e-4c35-b4ff-b2bb5ab68649
Provenance: Derivation Web chain
Citation Support
source_1Mohammadnia 2025source_2Li 2025source_3Ammirati 2026source_4Pascart 2026source_5Broekhoven 2022